TROJE, spoken TRO AY
Direct to consumer health  |  Global

Turn consumer choice into starts.

TROJE helps healthcare organizations reach more qualified patients, launch faster, and build pathways people can actually move through, from first interest to treatment or trial.

Direct to consumer health is the strategy. A start is the proof.

Grow revenue and share. Reach more qualified patients. Move faster. Waste less. Improve experience.

What the work changes

Business value people can feel.

Growth

Build new revenue and share from capabilities you already have.

Reach

Connect more qualified patients to the right next step.

Efficiency

Reduce wasted referrals, screens, rework, and handoffs.

Experience

Keep patients and clinicians within relationships they trust.

We agree on the outcome, measure, and date before the work begins.

The opportunity

The pieces exist. The pathway does not.

Most organizations already have the platforms, partners, pharmacies, data, and clinical expertise. TROJE connects the handoffs so a person can move forward.

Coverage is not access. Activity is not adoption. A start is.
Advisory that stays through delivery

Decide. Build. Scale.

We find where the work stalls, fix the handoffs, and leave a model your team can run.

Decide

Choose what to build, buy, or partner. Know why.

Build

Connect the people, partners, workflows, and measures.

Scale

Run it, improve it, and leave your team ready to own it.

Principal led. Bench enabled. Client integrated. A TROJE principal stays accountable. Senior specialists join when needed. Your team owns what remains.

The experience behind TROJE

Built at national scale. Adapted across markets.

5,000+ stores

National infrastructure. Built a clinical research platform for a 5,000+ store enterprise.

3× benchmark

Referral performance. Launched 20+ studies in year one and delivered referrals at three times the benchmark.

6× faster

Enterprise execution. Reduced an implementation timeline from 18 months to 3.

Global frameworks

Designed and deployed across countries, markets, segments, and therapeutic areas, connecting commercialization with clinical trial infrastructure.

Global to local

One global core. Adapted by market. Delivered locally.

Keep the strategy, evidence, data, and standards consistent. Adapt regulation, reimbursement, language, culture, partners, and delivery by market.

Build once. Adapt faster. Learn everywhere.
Start here

What are you trying to launch, fix, or scale?

Tell us the goal, deadline, and where the work is stuck. We will tell you quickly whether we can help.

Oncology · Rare and orphan · Cardiometabolic · Immunology · Neuroscience · HIV
Product

In development.

A protected clinical intelligence capability.